Clinical Trials
6
Active:0
Completed:5
Trial Phases
3 Phases
Phase 2:2
Phase 4:2
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (33.3%)Phase 2
2 (33.3%)Phase 4
2 (33.3%)Omega Tots Long Term Follow-up
Not Applicable
- Conditions
- Child DevelopmentPreterm Birth
- Interventions
- Drug: Docosahexaenoic Acid + Arachidonic Acid (DHA+AA)Dietary Supplement: Placebo
- First Posted Date
- 2022-01-14
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- Sarah Keim
- Target Recruit Count
- 377
- Registration Number
- NCT05191823
- Locations
- 🇺🇸
Nationwide Children's Hospital, Columbus, Ohio, United States
Fatty Acid Supplementation in Children With ASD (Study 2)
Phase 2
Completed
- Conditions
- Autism Spectrum Disorder
- Interventions
- Drug: LCPUFA Oil SupplementDietary Supplement: Canola Oil Placebo
- First Posted Date
- 2020-03-18
- Last Posted Date
- 2024-07-12
- Lead Sponsor
- Sarah Keim
- Target Recruit Count
- 98
- Registration Number
- NCT04312932
- Locations
- 🇺🇸
Nationwide Children's Hospital, Columbus, Ohio, United States
Physical Activity Intervention for Gestational Diabetes
Not Applicable
Completed
- Conditions
- Gestational Diabetes
- First Posted Date
- 2018-09-10
- Last Posted Date
- 2022-07-20
- Lead Sponsor
- Sarah Keim
- Target Recruit Count
- 75
- Registration Number
- NCT03664089
- Locations
- 🇺🇸
Nationwide Children's Hospital, Columbus, Ohio, United States
Fatty Acid Supplementation in Children With ASD
Phase 2
Completed
- Conditions
- Autism Spectrum Disorder
- Interventions
- Drug: LCPUFA Oil SupplementDietary Supplement: Canola Oil Placebo
- First Posted Date
- 2018-06-08
- Last Posted Date
- 2021-08-03
- Lead Sponsor
- Sarah Keim
- Target Recruit Count
- 72
- Registration Number
- NCT03550209
- Locations
- 🇺🇸
Nationwide Children's Hospital, Columbus, Ohio, United States
Preemie Tots: A Pilot Study to Understand the Effects of Prematurity in Toddlerhood
Phase 4
Completed
- Conditions
- Child DevelopmentChild BehaviorPreterm Birth
- Interventions
- Drug: LCPUFA oil supplementOther: Canola Oil Placebo
- First Posted Date
- 2012-09-12
- Last Posted Date
- 2019-01-03
- Lead Sponsor
- Sarah Keim
- Target Recruit Count
- 31
- Registration Number
- NCT01683565
- Locations
- 🇺🇸
Nationwide Children's Hospital, Columbus, Ohio, United States
- Prev
- 1
- 2
- Next
News
No news found